Page last updated: 2024-08-24

carbogen and Nasopharyngeal Neoplasms

carbogen has been researched along with Nasopharyngeal Neoplasms in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (100.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Chaosu, H; Chunying, S; Xiaoshen, W; Xueguan, L; Yan, F; Yongsheng, Z	1

Other Studies

1 other study(ies) available for carbogen and Nasopharyngeal Neoplasms

Article	Year
Hypoxia inducible factor-1 alpha and vascular endothelial growth factor expression are associated with a poor prognosis in patients with nasopharyngeal carcinoma receiving radiotherapy with carbogen and nicotinamide. Clinical oncology (Royal College of Radiologists (Great Britain)), 2008, Volume: 20, Issue:8 Topics: Adult; Aged; Biomarkers; Carbon Dioxide; Female; Gene Expression; Humans; Hypoxia-Inducible Factor 1, alpha Subunit; Male; Middle Aged; Nasopharyngeal Neoplasms; Niacinamide; Oxygen; Prognosis; Radiation-Sensitizing Agents; Survival Analysis; Vascular Endothelial Growth Factor A	2008

Article

Year

Hypoxia inducible factor-1 alpha and vascular endothelial growth factor expression are associated with a poor prognosis in patients with nasopharyngeal carcinoma receiving radiotherapy with carbogen and nicotinamide.

Clinical oncology (Royal College of Radiologists (Great Britain)), 2008, Volume: 20, Issue:8

Topics: Adult; Aged; Biomarkers; Carbon Dioxide; Female; Gene Expression; Humans; Hypoxia-Inducible Factor 1, alpha Subunit; Male; Middle Aged; Nasopharyngeal Neoplasms; Niacinamide; Oxygen; Prognosis; Radiation-Sensitizing Agents; Survival Analysis; Vascular Endothelial Growth Factor A

2008